Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Bankruptcy is a real possibility

<< Previous

Bullboard Posts

Next >>

Comment by tdon1229on Jul 12, 2024 10:05am

147 Views

Post# 36130005

RE:RE:Bankruptcy is a real possibility

The other day I looked back over the PP history all the way to 2015, and noted that they were usually set at $10 million (CDN), though they didn't seem to ever reach that limit, regardless of how many tranches they employed.
Those interested in following the trail can go to the quote page, scroll down below the chart to the news links, and go page by page back through the NR history.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments